Shares of National Health Investors, Inc. (NYSE:NHI – Get Free Report) have earned an average recommendation of “Moderate Buy” from the six brokerages that are presently covering the company, MarketBeat reports. Two analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $75.33.
NHI has been the subject of several analyst reports. Bank of America initiated coverage on National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 target price for the company. Wells Fargo & Company lowered shares of National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their price objective for the stock from $81.00 to $86.00 in a research note on Tuesday, October 1st. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Finally, Truist Financial decreased their price objective on shares of National Health Investors from $78.00 to $72.00 and set a “hold” rating for the company in a report on Monday, December 23rd.
Check Out Our Latest Stock Analysis on NHI
Institutional Trading of National Health Investors
National Health Investors Price Performance
Shares of NYSE:NHI opened at $66.91 on Tuesday. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. National Health Investors has a 12 month low of $51.59 and a 12 month high of $86.13. The stock has a market capitalization of $3.04 billion, a PE ratio of 22.99, a PEG ratio of 4.86 and a beta of 1.06. The firm has a 50 day moving average of $74.43 and a 200-day moving average of $75.87.
National Health Investors (NYSE:NHI – Get Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The company had revenue of $63.32 million during the quarter, compared to analyst estimates of $67.93 million. During the same period in the prior year, the firm earned $1.08 earnings per share. National Health Investors’s revenue was up 1.7% compared to the same quarter last year. On average, equities research analysts predict that National Health Investors will post 4.42 EPS for the current fiscal year.
National Health Investors Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be issued a $0.90 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 annualized dividend and a yield of 5.38%. National Health Investors’s dividend payout ratio (DPR) is 123.71%.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
See Also
- Five stocks we like better than National Health Investors
- 3 REITs to Buy and Hold for the Long Term
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- How to Invest in Insurance Companies: A GuideĀ
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.